CN Patent

CN103990107A — 用gnrh拮抗剂地加瑞克治疗前列腺癌的方法

Assigned to Ferring International Center (switzerland) S A · Expires 2014-08-20 · 12y expired

What this patent protects

本发明提供促性腺激素释放激素(GnRH)拮抗剂用于安全和有效治疗雄激素依赖性前列腺癌而不会导致睾酮峰值和/或GnRH激动剂疗法的其它副作用如尿道感染、或关节痛相关或心血管副作用的应用和给药方案。

USPTO Abstract

本发明提供促性腺激素释放激素(GnRH)拮抗剂用于安全和有效治疗雄激素依赖性前列腺癌而不会导致睾酮峰值和/或GnRH激动剂疗法的其它副作用如尿道感染、或关节痛相关或心血管副作用的应用和给药方案。

Drugs covered by this patent

Patent Metadata

Patent number
CN103990107A
Jurisdiction
CN
Classification
—
Expires
2014-08-20
Drug substance claim
No
Drug product claim
No
Assignee
Ferring International Center (switzerland) S A
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.